{"id":"W4400109243","doi":"10.1200/jco.2024.42.16_suppl.7007","title":"Efficacy and safety of ibrutinib plus venetoclax in patients with mantle cell lymphoma (MCL) and <i>TP53</i> mutations in the SYMPATICO study.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Ven; Venetoclax; Ibrutinib; Mantle cell lymphoma; Internal medicine; Hazard ratio; Population; Phases of clinical research; Bendamustine; Neutropenia; Gastroenterology; Oncology; Rituximab; Toxicity; Lymphoma; Confidence interval; Leukemia; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001974178,0.000922497,0.001413978,0.0003902173,0.000322214,0.0009505402,0.0006565173,0.0007451717,0.001747992],"category_scores_gemma":[0.001067149,0.0003859357,0.002197922,0.0005385291,0.0005426952,0.0007094584,0.0005231622,0.001920824,0.0003499123],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007272211,"about_ca_system_score_gemma":0.001089212,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009561473,"about_ca_topic_score_gemma":0.002793902,"domain_scores_codex":[0.9993472,0.0003394643,0.00003716948,0.0001045911,0.0000827462,0.0000888236],"domain_scores_gemma":[0.9991186,0.0001275688,0.0002527127,0.00008333327,0.00005081842,0.0003669267],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8531271,0.008793204,0.04809082,0.000804806,0.006373926,0.0001672677,0.0002191261,0.001517018,0.01236497,0.0002396257,0.004682618,0.06361958],"study_design_scores_gemma":[0.5290313,0.25542,0.1966238,0.0001556581,0.007516909,0.0005803384,0.0002089061,0.002082811,0.001789932,0.0006572353,0.005846472,0.00008676693],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930066,0.003251575,0.0001707296,0.0002503613,0.00008829346,0.0002418744,0.00148176,0.00002721317,0.001481618],"genre_scores_gemma":[0.9936759,0.001177651,0.0003492129,0.0004988633,0.0001478615,0.0003028256,0.003254554,0.00001115852,0.0005820157],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001974178,"threshold_uncertainty_score":0.01044059,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04951817572860148,"score_gpt":0.4189142326057971,"score_spread":0.3693960568771957,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}